MT1A and cancer: Metallothionein-1 (MT1) is usually downregulated in CRC, so its upregulation as a result of 5-fluorouracil treatment could result in improved survival rates in colorectal cancer, potentially due to its role in promoting cancer cell differentiation (Arriaga et al., 2017).